Insights

Thought leadership pieces from subject matter experts inside of Fresenius Medical Care North America

Quality Management: Solutions That Meet the Challenge

by Jeffrey Hymes, MD

published June 22, 2018

As the number of medically needy patients with ESRD increases, the clinic team has less time to analyze an ever-increasing amount of valuable data on patient outcomes.
whitepaper

Cardiovascular Benefits of More Frequent Hemodialysis

by Dinesh Chatoth, MD & Allan Collins, MD, FACP

published June 22, 2018

Shorter, more frequent dialysis treatments can help improve cardiovascular complications and quality of life for end-stage renal disease (ESRD) patients.
whitepaper

Caring for Caregivers

by Dugan Maddux, MD, FACP

published June 22, 2018

Family members and friends often play a significant role as caregivers for people with end-stage renal disease (ESRD) and other chronic conditions.
whitepaper

Leading Innovation Through Value-Based Care

by Andrew Aronson, MD, FACEP & William McKinney

published June 22, 2018

As the leader in value-based care (VBC) for patients with end-stage renal disease (ESRD), Fresenius Medical Care North America (FMCNA) is in an ideal position to drive health care innovation.
whitepaper

Antibiotic Stewardship

by Terry Ketchersid, MD, MBA

published June 22, 2018

Fresenius Medical Care North America (FMCNA) has established an antibiotic stewardship program to help minimize the unintended consequences of antibiotic use in patients with end-stage renal disease (ESRD).
whitepaper

F1RST Up®: Accelerating Clinical Trial Start-Up

by Kurt Mussina, MBA & Christina Kahn

published June 22, 2018

Despite the pressing need to bring novel therapies to patients with renal impairments, the development time and cost to bring new drugs and medical devices to market has actually increased over the past decade.
whitepaper

The Real-World Effectiveness of Velphoro in Patients on Chronic Dialysis

by Linda Ficociello, DSc, Robert J. Kossmann, MD, FACP, FASN & Claudy Mullon, PhD

published June 22, 2018

Fresenius Kidney Care (FKC) has been studying the real-world effectiveness of Velphoro to see if a lower pill burden helps patients increase adherence and reduce their serum phosphorus levels.
whitepaper

Listening Through Numbers

by Len Usvyat, PhD & Tommy Blanchard, PhD

published June 22, 2018

As technology continues to improve, our ability to aggregate and gain actionable insight from diverse data sources is increasing dramatically.
whitepaper